Andrew Newton 
ADVERTISEMENT
Most Read on APEsphere
Most Commented on APEsphere
Blogs we like
Resources
Drug companies accused of unethical trials in India
Add this link to:
Related Links
Report Abuse:
So that we can keep the site friendly, legal and on-topic, please click the Report Abuse button if this story breaks the APEsphere Code.
Added by
apesphere on 09 Feb 2009
From: somo.nl
|
| Image courtesy SMercury98 via Flickr |
A report commissioned by SOMO, the Dutch multinationals watchdog, accuses drug companies of exploiting the desperation of those without choices.
GlaxoSmithKline is said to have tested a then experimental cancer drug Lapatinib on Indian women who were not first given the opportunity to try already tested treatments, as they would have been in Western European countries.
AstraZeneca is alleged to have given schizophrenia patients a placebo treatment in another trial detailed in the report used to illustrate how little benefit Indian trial participants get from their involvement.
The timing of the publication of the report is not accidental. A new advocacy organisation has also been launched at FairDrugs.org to call for respect of the rights of trial participants in developing countries.
GlaxoSmithKline is said to have tested a then experimental cancer drug Lapatinib on Indian women who were not first given the opportunity to try already tested treatments, as they would have been in Western European countries.
AstraZeneca is alleged to have given schizophrenia patients a placebo treatment in another trial detailed in the report used to illustrate how little benefit Indian trial participants get from their involvement.
The timing of the publication of the report is not accidental. A new advocacy organisation has also been launched at FairDrugs.org to call for respect of the rights of trial participants in developing countries.
Andrew Newton is the author of The Handbook of Compliance: Making Ethics Work in Financial Services
Comments
Add a comment